Lanzamiento Enero 2027

Ensayo controlado aleatorizado2023Acceso abierto

A 2-yr Randomized Controlled Trial on Creatine Supplementation during Exercise for Postmenopausal Bone Health

Chilibeck PD, Candow DG, Gordon JJ, Duff WRD, Mason R, Shaw K, Taylor-Gjevre R, Nair B, Zello GA

Medicine and science in sports and exercise · 24 citas

Cómo se estudió

Diseño
Ensayo controlado aleatorizado (indexado por PubMed)
Estudiado en
Personas
Resultado principal
Marcadores de salud y funcionamiento

Quién lo pagó

Financiación
Financiación independiente
Gobierno
Canadian Institutes of Health Research
Gobierno
CIHR
Subvenciones
Canadian Institutes of Health Research (130235)

Según 2 financiadores declarados.

Publicación

Publicado
2023-05-05 · Med Sci Sports Exerc · vol. 55 · número 10 · págs. 1750–1760
Editorial
Lippincott Williams & Wilkins
Citado
36 citas · más que el 96% de estudios similares · 4.6× el promedio de su campo
Impacto
Entre el 10 % más citado de su campo
Referencias
49 trabajos
Acceso
Acceso abierto (revista híbrida) · CC-BY-NC-ND
Áreas de investigación
Muscle metabolism and nutrition · Bone health and osteoporosis research · Cardiovascular and exercise physiology
Palabras clave
Creatine, Randomized controlled trial, Bone health, Physical therapy, Medicine, Postmenopausal women, Internal medicine, Physical medicine and rehabilitation, Osteoporosis, Bone mineral
MeSH
femur neck, humans, osteoporosis, postmenopausal, creatine, double-blind method, postmenopause, bone density, dietary supplements, middle aged, female

9 autores

  • Philip David Chilibeck🇨🇦 · autor de correspondenciaUniversity of Saskatchewan
  • Darren Glenn Candow🇨🇦University of Regina
  • Julianne J. Gordon🇨🇦University of Saskatchewan
  • WHITNEY R. D. DUFF🇨🇦University of Saskatchewan
  • Riley Mason🇨🇦University of Saskatchewan
  • Keely A. Shaw🇨🇦University of Saskatchewan
  • Regina M. Taylor‐Gjevre🇨🇦University of Saskatchewan
  • Bindu Nair🇨🇦University of Saskatchewan
  • Gordon Alexander Zello🇨🇦University of Saskatchewan

Resumen

El texto original del estudio, en el idioma en que se publicó.

Purpose

Our purpose was to examine the effects of 2 yr of creatine monohydrate supplementation and exercise on bone health in postmenopausal women.

Methods

Two hundred and thirty-seven postmenopausal women (mean age, 59 yr) were randomized to receive creatine (0.14 g·kg -1 ·d -1 ) or placebo during a resistance training (3 d·wk -1 ) and walking (6 d·wk -1 ) program for 2 yr. Our primary outcome was the femoral neck bone mineral density (BMD), with lumbar spine BMD and proximal femur geometric properties as the secondary outcomes.

Results

Compared with placebo, creatine supplementation had no effect on BMD of the femoral neck (creatine: 0.725 ± 0.110 to 0.712 ± 0.100 g·cm -2 ; placebo: 0.721 ± 0.102 to 0.706 ± 0.097 g·cm -2 ), total hip (creatine: 0.879 ± 0.118 to 0.872 ± 0.114 g·cm -2 ; placebo: 0.881 ± 0.111 to 0.873 ± 0.109 g·cm -2 ), or lumbar spine (creatine: 0.932 ± 0.133 to 0.925 ± 0.131 g·cm -2 ; placebo: 0.923 ± 0.145 to 0.915 ± 0.143 g·cm -2 ). Creatine significantly maintained section modulus (1.35 ± 0.29 to 1.34 ± 0.26 vs 1.34 ± 0.25 to 1.28 ± 0.23 cm 3 (placebo), P = 0.0011), predictive of bone bending strength, and buckling ratio (10.8 ± 2.6 to 11.1 ± 2.2 vs 11.0 ± 2.6 to 11.6 ± 2.7 (placebo), P = 0.011), predictive of reduced cortical bending under compressive loads, at the narrow part of the femoral neck. Creatine reduced walking time over 80 m (48.6 ± 5.6 to 47.1 ± 5.4 vs 48.3 ± 4.5 to 48.2 ± 4.9 s (placebo), P = 0.0008) but had no effect on muscular strength (i.e., one-repetition maximum) during bench press (32.1 ± 12.7 to 42.6 ± 14.1 vs 30.6 ± 10.9 to 41.4 ± 14 kg (placebo)) and hack squat (57.6 ± 21.6 to 84.4 ± 28.1 vs 56.6 ± 24.0 to 82.7 ± 25.0 kg (placebo)). In the subanalysis of valid completers, creatine increased lean tissue mass compared with placebo (40.8 ± 5.7 to 43.1 ± 5.9 vs 40.4 ± 5.3 to 42.0 ± 5.2 kg (placebo), P = 0.046).

Conclusions

Two years of creatine supplementation and exercise in postmenopausal women had no effect on BMD; yet, it improved some bone geometric properties at the proximal femur.

Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial (CC BY-NC-ND).

Confianza de la comunidad

Cargando…

¿Cuánto confías en los hallazgos de este estudio?

0 · nada10 · totalmente

Comentarios

¿Algo está mal aquí?

Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.

Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.